BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-118@pharmaconomics
DTSTAMP:20260707T010022Z
DTSTART;VALUE=DATE:20260831
DTEND;VALUE=DATE:20260901
SUMMARY:ACRS Phase 2 — ATI-045 (estimated date)
DESCRIPTION:Phase 2 trial results for ATI-045 in Atopic Dermatitis are due ~ Aug 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT07011706\n\nTrack it: https://www.pharmaconomics.com/e/118
URL:https://www.pharmaconomics.com/e/118
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ACRS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR